Results

Total Results: 1,401 records

Showing results for "adverse".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-i.xlsx
    January 01, 2019 - Definitely yes Age only effect modifier considered for adverse events. … ) of adverse events are evaluated for potential modification. … Many adverse events analyzed for potential modification. 40905 CRITICS Age Yes Grade 3 to 5 adverse … ) of adverse events are evaluated for potential modification. … Many adverse events analyzed for potential modification.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
    September 01, 2012 - How do the effectiveness, acceptability, adherence, adverse effects, and safety of progestogen treatment … provided some information on adverse effects of progestogen treatment. … In general, clinical trials have lacked statistical power to identify distinct differences in adverse … No adverse effects were recorded in studies of suppositories, while multiple adverse effects were reported … Four studies reported adverse effects; none were linked to dose or frequency of treatment.
  3. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
    July 01, 2009 - There were 84 studies that reported at least one adverse event associated with RFA. … Most of the studies did not report the time of occurrence of the adverse events. … Major adverse events associated with RFA are relatively uncommon. … the various adverse events were not always comparable. … All studies should actively collect adverse event data from study participants.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
    October 01, 2014 - This includes: • Overall adverse events. • Specific adverse events. … • Persistence and reversibility of adverse events. … This includes: • Overall adverse events. • Specific adverse events. … Adverse Events Twelve studies provided adverse-events data for FGAs versus SGAs. … Key Question 2: Adverse Events Twelve studies provided adverse-events data for FGAs versus SGAs.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
    April 18, 2013 - effects and adverse effects that lead to treatment discontinuation.” … Pediatric safety trials should examine adverse effects at 12 months or more. … We added tables with dose response association with adverse drug effects in children. … We reviewed all evidence of adverse effects with drugs. … We analyzed specific safety outcome (specific adverse effects or treatment discontinuation due to adverse
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
    September 13, 2024 - cognitive impairment, and substance use disorders.10 This project will investigate the epidemiology and adverse … Outcome o Short-term  Overdoses, fatal and non-fatal  Health measures (cardiovascular, injuries, adverse … term")) OR (title: ("long term")) OR (title: ("longer term")) OR (title: (outcomes)) OR (title: ("adverse … event")) OR (title: ("adverse events")) OR (title: (consequence)) OR (title: (consequences)) OR (title … event")) OR (abstract: ("adverse events")) OR (abstract: (consequence)) OR (abstract: (consequences
  7. effectivehealthcare.ahrq.gov/products/mhs4-computerized-cds/rapid-research
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_executive.pdf
    April 01, 2013 - adverse events for various interventions. … capturing adverse events often were not reported. … For most of the specific adverse events, point estimates favored placebo (more adverse events with … Regarding adverse events, future studies could include validated measures of adverse effects, including … methods for systematically capturing adverse events, and more complete reporting of adverse events.
  9. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
    September 01, 2011 - Key Question 3: What are the short-term and long- term adverse events associated with specific medical … Does the incidence of adverse events vary with duration of followup, specific surgical intervention, … To evaluate adverse events and complications (Key Question 3), we assessed the rate of each adverse event … Both could help ferret out any possible association between treatment and adverse events. … Adverse events Low • None of the quantitative estimates of adverse events are reliable because of a
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
    September 18, 2012 - Our work will expand the consensus report Adverse Effects of Vaccines: Evidence and Causality, which … (CTCAE) classification system, and serious adverse events (SAE) will be defined and coded. … The absolute risk of serious adverse events (SAEs) will also be computed. … event CTCAE = Common Terminology Criteria for Adverse Events Hib = Haemophilus influenzae type b … Adverse events of interest, included in electronic search terms Adverse event Vaccine type Acute
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - a systematic review evaluating the evidence regarding the efficacy, comparative effectiveness, and adverse … Adult Dosing Mechanism of Action Common Adverse Effects Contraindications Acamprosate Oral: 666 mg ( … causing accumulation of acetaldehyde during alcohol consumption, which, in turn, produces various adverse … Clinicians are advised to refer to the prescribing information sheet for additional information on adverse … efficacy and relative effectiveness of the various medications for AUD �� Evidence related to the adverse
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
    November 01, 2016 - Pharmacological therapies are associated with increased risk of adverse events when compared with placebo … �» Examples of reported adverse effects included mild bleeding at needling sites with acupuncture, … �» Although rates appeared to be low and there was no increased risk of serious adverse effects versus … in the report or to the drug labels of each drug for comprehensive information on their potential adverse … Table 4: Adverse Effects of Interventions for Low Back Pain Table 3: Nonradicular Chronic Low Back Pain
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
    September 01, 2014 - .  � The evidence is insufficient to understand the adverse events from all other medical interventions … Other Interventions � The evidence is insufficient to understand the effectiveness, benefits, or adverse … educational intervention.  � The evidence is insufficient to understand the effectiveness, benefits, or adverse … and aripiprazole, there was not enough evidence to estimate the severity and frequency of potential adverse … which no research has been conducted and on atypical antipsychotics that may be less associated with adverse
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - The rate and type of adverse events did not differ between treatment groups in these studies. … comparisons of the rate and type of adverse events among the various DMARDs. … Adverse events were generally mild, and the four serious adverse events resolved spontaneously or … The rate and type of adverse events did not differ between treatment groups in these studies. … comparisons of the rate and type of adverse events among the various DMARDs.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - The rate and type of adverse events did not differ between treatment groups in these studies. … comparisons of the rate and type of adverse events among the various DMARDs. … Adverse events were generally mild, and the four serious adverse events resolved spontaneously or … The rate and type of adverse events did not differ between treatment groups in these studies. … comparisons of the rate and type of adverse events among the various DMARDs.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-executive-summary.pdf
    March 01, 2024 - • The identified diagnostic studies did not assess the adverse effects of being labeled correctly … significant differences between stimulant and non-stimulant medications for most effectiveness outcomes and adverse … Furthermore, the identified studies did not assess the adverse effects of being labeled correctly or … effectiveness outcomes, such as ADHD symptoms (SMD 0.23; CI -0.03, 0.49; 7 studies, n=1611; low SoE) and adverse … Across studies, medication therapy evaluations reported more adverse events than non-medication interventions
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
    March 27, 2014 - In children with JIA, does the rate and type of adverse eventsf differ between the various DMARDs or … How do the efficacy, effectiveness, safety, and adverse effects of treatment with DMARDs differ among … with DMARDs, we focused primarily on serious infections and the development of cancer when assessing adverse … Other adverse events considered included mortality, hepatitis, bone marrow suppression, nausea or vomiting
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
    September 30, 2015 - Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse … Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration: 6 weeks University … Abbreviations: AE = adverse event; BMI = body mass index; CI = confidence interval; COWS = Clinical Opiate … ; PCP = primary care provider; RCT = randomized controlled trial; RR = relative risk; SAE = serious adverse … event B) Controls: (n=2,311), patients without an opioid-related adverse event, 1:1 matching based on
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
    May 01, 2016 - systematic review evaluating the evidence regarding the effectiveness, comparative effectiveness, and adverse … Topiramate also increased binge-eating abstinence. �� Adverse effects of BED treatments were mainly … use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse … Table 2: Summary of Key Findings for Adverse Effects of Pharmacological Interventions Intervention and … events, serious adverse events, and study discontinuations clearly attributable to adverse events,
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
    September 01, 2014 - We recommend that the authors define what is meant by “Serious Adverse Events”. … PG10: “Serious Adverse Events” are listed as an outcome without definition. … PG37: Again, “Serious Adverse Events” is undefined. … events or in the number of discontinuations due to adverse events.” … “Renal-related Adverse Events” is a more appropriate section header. 2.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: